These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12904102)

  • 1. Safety of immunisation and adverse events following vaccination against hepatitis B.
    Duclos P
    Expert Opin Drug Saf; 2003 May; 2(3):225-31. PubMed ID: 12904102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of hepatitis B vaccination.
    Geier MR; Geier DA; Zahalsky AC
    Expert Opin Drug Saf; 2003 Mar; 2(2):113-22. PubMed ID: 12904111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: analysis of the Vaccine Adverse Event Reporting System (VAERS) database and literature review.
    Geier MR; Geier DA
    Clin Exp Rheumatol; 2004; 22(6):749-55. PubMed ID: 15638050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B immunisation in persons not previously exposed to hepatitis B or with unknown exposure status.
    Mathew JL; El Dib R; Mathew PJ; Boxall EH; Brok J
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006481. PubMed ID: 18677780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oral levamisole as an adjuvant to hepatitis B vaccine in adults with end-stage renal disease: a meta-analysis of controlled clinical trials.
    Alavian SM; Tabatabaei SV
    Clin Ther; 2010 Jan; 32(1):1-10. PubMed ID: 20171406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case-control study of serious autoimmune adverse events following hepatitis B immunization.
    Geier DA; Geier MR
    Autoimmunity; 2005 Jun; 38(4):295-301. PubMed ID: 16206512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in the hepatitis B related burden of disease--measuring the success of universal immunisation programs.
    Williams A
    Commun Dis Intell Q Rep; 2002; 26(3):458-60. PubMed ID: 12416714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The global impact of vaccination against hepatitis B: a historical overview.
    Zanetti AR; Van Damme P; Shouval D
    Vaccine; 2008 Nov; 26(49):6266-73. PubMed ID: 18848855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The worldwide impact of vaccination on the control and protection of viral hepatitis B.
    Romano' L; Paladini S; Van Damme P; Zanetti AR
    Dig Liver Dis; 2011 Jan; 43 Suppl 1():S2-7. PubMed ID: 21195368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.
    Whittle HC; Maine N; Pilkington J; Mendy M; Fortuin M; Bunn J; Allison L; Howard C; Hall A
    Lancet; 1995 Apr; 345(8957):1089-92. PubMed ID: 7715343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unsolved problems and future perspectives of hepatitis B virus vaccination.
    Tajiri K; Shimizu Y
    World J Gastroenterol; 2015 Jun; 21(23):7074-83. PubMed ID: 26109794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.
    Mast EE; Weinbaum CM; Fiore AE; Alter MJ; Bell BP; Finelli L; Rodewald LE; Douglas JM; Janssen RS; Ward JW;
    MMWR Recomm Rep; 2006 Dec; 55(RR-16):1-33; quiz CE1-4. PubMed ID: 17159833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B vaccine: risks and benefits of universal neonatal vaccination.
    MacIntyre CR
    J Paediatr Child Health; 2001 Jun; 37(3):215-7. PubMed ID: 11474704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global control of hepatitis B virus infection.
    Kao JH; Chen DS
    Lancet Infect Dis; 2002 Jul; 2(7):395-403. PubMed ID: 12127351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy.
    Bonanni P; Pesavento G; Bechini A; Tiscione E; Mannelli F; Benucci C; Nostro AL
    Vaccine; 2003 Jan; 21(7-8):685-91. PubMed ID: 12531340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the safety of hepatitis B vaccination during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 1990-2016.
    Moro PL; Zheteyeva Y; Barash F; Lewis P; Cano M
    Vaccine; 2018 Jan; 36(1):50-54. PubMed ID: 29174107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of vaccination against hepatitis B in patients with rheumatoid arthritis.
    Elkayam O; Yaron M; Caspi D
    Ann Rheum Dis; 2002 Jul; 61(7):623-5. PubMed ID: 12079904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.
    Tsebe KV; Burnett RJ; Hlungwani NP; Sibara MM; Venter PA; Mphahlele MJ
    Vaccine; 2001 Jul; 19(28-29):3919-26. PubMed ID: 11427266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination against hepatitis A and B: developments, deployment and delusions.
    Zuckerman JN
    Curr Opin Infect Dis; 2006 Oct; 19(5):456-9. PubMed ID: 16940869
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.